Jonathan Rubin, MD
Supernus Pharmaceuticals, Inc. · Chief Medical Officer · Univeristy of Michigan Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jonathan Rubin, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:05 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05097079 · Efficacy and Safety Study of MYOBLOC in the Treatment of Sialorrhea in Pediatric SubjectsSolstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC · withdrawn · Sialorrhea · study director
- Ph4NCT04786990 · Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHDSupernus Pharmaceuticals, Inc. · completed · Attention-Deficit/Hyperactivity Disorder (ADHD) · study director
- Ph3NCT04143217 · Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHDSupernus Pharmaceuticals, Inc. · completed · Attention-Deficit/Hyperactivity Disorder · study director
- Ph3NCT04016779 · Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHDSupernus Pharmaceuticals, Inc. · completed · Attention-Deficit/Hyperactivity Disorder (ADHD) · study director
- Ph3NCT03247543 · Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHDSupernus Pharmaceuticals, Inc. · completed · ADHD · study director
- Ph3NCT03247556 · Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHDSupernus Pharmaceuticals, Inc. · completed · ADHD · study director
- Ph3NCT02736656 · Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)Supernus Pharmaceuticals, Inc. · active not recruiting · Attention-Deficit/Hyperactivity Disorder · study director
- Ph3NCT01994109 · Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult SubjectsSolstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC · completed · Sialorrhea · study director
- Ph1/Ph2NCT01107496 · Evaluation of Immediate-Release Viloxazine in Adults With ADHDSupernus Pharmaceuticals, Inc. · completed · Attention-Deficit/Hyperactivity Disorder (ADHD) · study director
- N/ANCT00847951 · Ultrasound for Perfusion in NeonatesUniversity of Michigan · withdrawn · Kidney Perfusion · principal investigator
- Ph2NCT00515437 · A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease PatientsSolstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC · completed · Drooling · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.